Clinical Trial Update: Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating memantine hydrochloride in combination with escitalopram for co-morbid depression and alcoholism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

Sponsor: Finnish Institute for Health and Welfare | Conditions: Alcoholism, Depression | Phase 4 | Status: COMPLETED